Overall Learning Objectives
Upon completion of this program, learners will be able to:
- Discuss and describe the different immunological drivers influenced by the presence or absence of TNF-? in the adaptive system, and their clinical manifestations.
- Outline strategies to achieve optimal patient outcomes by utilizing a joint approach to management of inflammatory diseases between gastroenterologists, rheumatologists, and dermatologists.
SESSION 1 - Dermatology Session
Presenter: Dr. Charles Lynde
Guest Faculty: Dr. Brian Bressler, Dr. Janet Pope
Session Objectives:
- Critically appraise the use of tumour necrosis factor inhibitors (TNFi) in patients with psoriatic arthritis (PsA)
- Proactively develop a management strategy for patients with psoriasis (PsO), especially skin changes
- Discuss and develop a collaborative referral approach for Dermatology cases that may require interventions from other specialists
SESSION 2 - Gastroenterology Session
Presenter: Dr. Brian Bressler
Guest Faculty: Dr. Charles Lynde, Dr. Janet Pope
Session Objectives:
- Describe the differential diagnoses for pyoderma grangrenosum and develop a tailored clinical management approach
- Compare and assess causes of functional versus inflammatory diarrheal conditions associated with psoriatic disease
- Discuss and develop a collaborative referral approach for gastroenterology cases that may require other specialist interventions
SESSION 3 - Rheumatology Session
Presenter: Dr. Janet Pope
Guest Faculty: Dr. Charles Lynde, Dr. Brian Bressler
Session Objectives:
- Accurately assess a patient’s psoriasis (PsO), including systemic PsO disease progression in rheumatic disease patients
- Appropriately manage a patient with rheumatoid arthritis (RA), recognizing when to alter treatment
- Discuss a collaborative referral approach for
Rheumatology cases with other specialists